Delivery Order SPE2DR25D2209-SPE2DR26FD6MX
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of Malarone 250-100 mg tablets in quantities of 100 units. This non-set-aside contract is valued at $26,388.91 and carries a firm fixed price structure, with an ultimate completion date of December 16, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of Malarone 250-100 mg tablets (100 count) with a ceiling value of $7,755.83. This firm fixed price delivery order, with an ultimate completion date of December 17, 2025, represents a competitively awarded, non-set-aside contract. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 17, 2025, for the supply of Malarone 250-100 mg tablets (100 count) with a ceiling value of $19,740.07. This firm fixed-price delivery order, issued without set-aside designation, represents a competitively awarded transaction under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Malarone 250-100 mg tablets (100-count units) valued at $1,363.98. This firm fixed-price delivery order, which is a child contract under a larger vehicle, has an ultimate completion date of September 18, 2025, and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. The award utilized no set-aside designation, indicating it was competitively...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on May 12, 2025, for the supply of Malarone 250-100 mg tablets (100-count units) at a contract ceiling value of $1,818.64. This firm fixed-price delivery order, with an ultimate completion date of May 13, 2025, represents a competitive award with no set-aside designation. The contract is performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Malarone 250-100 mg tablets (100 count) with a contract value of $3,182.62. This is a firm fixed-price delivery order with no set-aside designation, executed as a competitive award. The order is scheduled for completion by September 29, 2025, and will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Malarone 250-100 mg tablets (100 count) with a ceiling value of $60,590.43. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively procured. The contract is scheduled for ultimate completion on September 15, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 3, 2025, for the supply of Malarone 250/100 (100 tablets) with a ceiling value of $4,303.64. This firm fixed price delivery order, which is not set-aside designated, represents a competitive award under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of Malarone 62.5-25 mg pediatric tablets (100-count units) at a ceiling value of $1,334.45. This competitively awarded, firm fixed-price contract, which is not set-aside, represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Malarone 250-100 mg tablets (100 count) with a ceiling value of $2,022.30. This contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion pharmaceutical prime vendor agreement...
- SPE2DR25D2209Indefinite Delivery Contract
- SPE2DR25D2209-SPE2DR26FD6MXDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 17, 2025, for the supply of Malarone 250-100 mg tablets (100 count) with a ceiling value of $7,593.63. This firm fixed-price delivery order, with an ultimate completion date of December 18, 2025, represents a small-value pharmaceutical procurement under the company's larger indefinite delivery contract with DLA Troop Support Medical. The award was competitively made with no set-aside designation, and performance will occur at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is part of AmerisourceBergen's $999,999,999 prime indefinite delivery contract (SPE2DX) with DLA Troop Support Medical, which runs through December 2026 and serves as a comprehensive global pharmaceutical support vehicle. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, is a critical vendor for federal military and veteran healthcare systems, supplying a broad range of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains. The company's contract awards with DLA demonstrate consistent capability to fulfill federal procurement requirements through open competition, supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.6k | 12/16/25 |